David M Thal
Dr. David Thal is an ARC DECRA fellow and Head of the Structural Pharmacology group at the Monash Institute of Pharmaceutical Sciences. He received his undergraduate degree in Biochemistry at the University of Texas at Austin (2005), and his Ph.D (2010) from the University of Michigan under the guidance of Dr. John J.G. Tesmer. In 2011, he moved to Australia to begin his post-doctoral research under Arthur Christopoulos and Patrick Sexton to broaden his expertise in GPCR pharmacology and allosteric modulation. His research is primarily aimed at understanding the structure and function of G Protein-Coupled Receptors (GPCRs) with a particular emphasis on allosteric modulation. His current research focuses on GPCR targets involved in CNS disorders such as Alzheimer’s disease and Schizophrenia. While much of his current work relies on X-ray crystallography, he looks forward complimenting his research with other biophysical techniques including NMR spectroscopy and Cryo-electron microscopy.
Abstracts this author is presenting: